Magnasense Press Releace

Investors

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

2025-01-22 13:53 KALLELSE TILL EXTRA BOLAGSSTÄMMA I MAGNASENSE AB (PUBL) Regulatory
2025-01-20 08:20 Magnasense avser att genomföra en företrädesemission av units om cirka 26 MSEK för att utveckla salivbaserad diagnostik som alternativ till blodtest och tidigarelägger publicering av Q4-rapport för 2024 Regulatory MAR
2025-01-20 08:20 Magnasense intends to carry out a rights issue of units of approx. SEK 26m to develop saliva-based diagnostics as an alternative to blood testing, and bring forward the publication of the Q4 2024 report Regulatory MAR
2024-12-20 21:10 Magnasense AB Completes RADx® Tech Project Under NIH Regulatory MAR
2024-11-15 08:00 Magnasense Interim Report July - September 2024 Regulatory MAR
2024-11-15 08:00 Magnasense Delårsrapport Juli - September 2024 Regulatory MAR
2024-11-05 13:25 Magnasense AB carries out previously announced directed share issue of 13,090,908 shares to Atlas Special Opportunities following called upon conversions of SEK 3.00 million Regulatory
PreviousNext

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

Subscribe to our press releases

By clicking the Sign Up button, you agree to the privacy policy

en_USEN
en_USEN es_ESES
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.